NuGenerex Immuno-Oncology
$0.01
1
+$0.01+9,900% Tuesday 16:09
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
30AprExpected
Expected EPS
0
Actual EPS
-0.0183
Financials
-Profit Margin
Unprofitable0Revenue
-1,738.54Net Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NUGX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.
Show more...
CEO
Employees
6
Country
US
ISIN
US67053X1028
Listings
0 Comments
Share your thoughts
FAQ
What is NuGenerex Immuno-Oncology stock price today?▼
The current price of NUGX is $0.01 USD — it has increased by +9,900% in the past 24 hours. Watch NuGenerex Immuno-Oncology stock price performance more closely on the chart.
What is NuGenerex Immuno-Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NuGenerex Immuno-Oncology stocks are traded under the ticker NUGX.
What is NuGenerex Immuno-Oncology market cap?▼
Today NuGenerex Immuno-Oncology has the market capitalization of 1M
What were NuGenerex Immuno-Oncology earnings last quarter?▼
NUGX earnings for the last quarter are -0.02 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NuGenerex Immuno-Oncology revenue for the last year?▼
NuGenerex Immuno-Oncology revenue for the last year amounts to 0 USD.
What is NuGenerex Immuno-Oncology net income for the last year?▼
NUGX net income for the last year is -1,738.54 USD.
How many employees does NuGenerex Immuno-Oncology have?▼
As of April 03, 2026, the company has 6 employees.
In which sector is NuGenerex Immuno-Oncology located?▼
NuGenerex Immuno-Oncology operates in the Other sector.
When did NuGenerex Immuno-Oncology complete a stock split?▼
NuGenerex Immuno-Oncology has not had any recent stock splits.
Where is NuGenerex Immuno-Oncology headquartered?▼
NuGenerex Immuno-Oncology is headquartered in Miramar, US.